Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
Become a Member | Sign in
Home>News>This Article

Vetter Offers Answers for the Future at the Pharma Congress 2013

Published: Tuesday, February 19, 2013
Last Updated: Tuesday, February 19, 2013
Bookmark and Share
Experts from the CDMO to discuss the challenges and solutions facing the industry.

Changing markets and potential solutions will be the highlight at the 15th Pharma Congress Production & Technology in Duesseldorf, Germany, March 19 - 20. Vetter, one of the worlds’ leading Contract and Development Manufacturing Organization, will present on a variety of informative core developments critical to the international pharmaceutical and biotech industries. Udo J. Vetter, chairman of the Vetter advisory board, will present the keynote address at the Congress focusing his comments on the future demands and challenges in pharmaceutical manufacturing. Vetter experts will address various topics including the needs for filling monoclonal antibodies, advantages and solutions of restricted access barrier systems (RABS) and the implementation of isolators for sterility tests as well as Vetter’s own supplier management system and the company’s new Center for Visual Inspection and Logistics.

Major changes taking place among the world’s leading pharmaceutical and biotech companies demand creative solutions to complex challenges by the manufacturing industry. The 15th Pharma Congress Production & Technology held in mid-March, will bring together representatives from the private and public sectors to discuss the current market trends. Vetter, an international specialist in aseptic filling, will present on best practices in sterile manufacturing and packaging.

Presenter and topics include Udo J. Vetter, who will be focusing on aseptic manufacturing at the Congress's keynote. The chairman of the Vetter advisory board will be speaking about the current market trends and their long-term effects on sterile production. He will also discuss changing technological and regulatory requirements and how innovative and flexible production plants can provide answers.

Joerg Zimmermann, Director Process Development and Implementation will present two case studies including Vetter’s experiences with fill-and-finish considerations for monoclonal antibodies and how certain challenges are already being met in the early phases. His second case study will cover the function and advantages of the restricted access barrier systems (RABS) in aseptic manufacturing and how to operate a RABS-based line successfully based on real life experience. Mr. Zimmermann will also moderate the ECA Barrier Systems Conference, one of the key sessions of the Congress.

Dr. Andreas Reicke, Team Coordinator at Vetter’s microbiology division will review a case study on the implementation of sterility test isolators. He will talk about regulatory demands and considerations in regards to design, location and utilities as well as project planning from beginning through to implementation.

Uli Kuchenbrod, Director Incoming Goods at Vetter, will give his insights into Vetter‘s supplier management system and incoming inspections as part of quality control. He will also address the operative challenges as well as the strategic considerations between a CDMO and its suppliers.

Thomas Ruebekeil, Director Investment Projects will introduce the new Vetter Ravensburg site. He will present the project plan and best practice as well as provide an update on the Center for Visual Inspection and Logistics including characteristics of the building itself and the use of regenerative energy and how it can be safely and efficiently used in the pharmaceutical sector.

All of the presentations are consistent with the goal of the international event which is to present lectures as technical applications "from users for users", primarily concentrating on their practical benefits.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Potential Persistent Tuberculosis Treatment
Researchers have discovered several first-in-class compounds that target hidden TB infections by attacking a critical process the bacteria use to survive in the hostile environment of the lungs.
Metabolic Profiles Distinguish Early Stage Ovarian Cancer with Unprecedented Accuracy
Studying blood serum compounds of different molecular weights has led scientists to a set of biomarkers that may enable development of a highly accurate screening test for early-stage ovarian cancer.
The Do’s and Don’ts of SPR Experiments
Surface Plasmon Resonance (SPR) is a technique that is becoming more widely used, particularly by anyone who wants to obtain accurate on (association) and off (dissociation) rates for biomolecular binding.
Long-Sought Protein Sensor for the ‘Sixth Sense’ Discovered
In a study led by scientists from The Scripps Research Institute (TSRI)the sensor protein for propioception has been identified.
New Anti-Malarial Drug Screening Model
University of South Florida researchers demonstrate novel chemogenomic profiling to identify drug targets for the most lethal strain of malaria.
Shedding Light on “Dark” Cellular Receptors
UNC and UCSF labs create a new research tool to find homes for two orphan cell-surface receptors, a crucial step toward finding better therapeutics and causes of drug side effects.
New, Better Test for Prostate Cancer
A study from Karolinska Institutet shows that a new test for prostate cancer is better at detecting aggressive cancer than PSA.
Giant Molecules Inhibit Ebola Infection
European researchers have designed a "giant" molecule formed by thirteen fullerenes covered by carbohydrates which, by blocking this receptor, are able to inhibit the cell infection by an artificial ebola virus model.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos